This independent RP-HPLC lab test confirms Retatrutide 10mg from Orbitrex Peptides at 99.810% purity. The analysis was conducted by Kovera Labs on May 9, 2026.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level of 99.810% indicates minimal contamination and high-grade synthesis.
Endotoxin testing passed at ≤ 0.5 EU/mL, and heavy metal screening confirmed negative results for arsenic, cadmium, lead, and mercury. Microbial sterility screening showed no growth, demonstrating safety standards for research applications. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.